Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Systemic lupus erythematosus | D008180 | HP_0002725 | M32 | — | 2 | — | — | — | 2 |
Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | — | 2 | — | — | — | 2 |
Arthritis | D001168 | HP_0001369 | M05-M14 | — | 2 | — | — | — | 2 |
Drug common name | ELSUBRUTINIB |
INN | elsubrutinib |
Description | Elsubrutinib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target tyrosine-protein kinase BTK. |
Classification | Small molecule |
Drug class | tyrosine kinase inhibitors: tyrosine kinase inhibitors Bruton's (Btk) inhibitors |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | C=CC(=O)N1CCC[C@@H](c2ccc(C(N)=O)c3[nH]ccc23)C1 |
PDB | — |
CAS-ID | 1643570-24-4 |
RxCUI | — |
ChEMBL ID | CHEMBL4594348 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 1487U1Q3IQ (ChemIDplus, GSRS) |